Sign In
Buy NVTA
$0.0190
+0 (+0%)
At Close: May 13, 2024
Moving Average Crossover Alert: Invitae
01:19pm, Wednesday, 01'st Jul 2020
Invitae Corporation (NVTA) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
6 Stocks That Could Shoot Higher
12:00am, Wednesday, 01'st Jul 2020
Stocks Analysis by Harry Boxer covering: Crocs Inc, Tesla Inc, Celldex Therapeutics Inc, GenMark Diagnostics Inc. Read Harry Boxer's latest article on Investing.com
Invitae: Exponential Growth In Genetic Testing
12:19pm, Tuesday, 30'th Jun 2020
Invitae is a growth leader in genetic testing. The company is growing at full speed, and it has enormous room for expansion going forward. Lack of profitability
7 Stocks That Could Jump Higher
12:00am, Tuesday, 30'th Jun 2020
Stocks Analysis by Harry Boxer covering: Boeing Co, Bed Bath & Beyond Inc, Ballard Power Systems Inc, Fluidigm Corporation. Read Harry Boxer's latest article on Investing.com
Coronavirus Flareup Sparked a Great Week for Active Genomics ETF
03:36pm, Monday, 29'th Jun 2020
The ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) jumped 5.34% last week
Could Invitae Be a Millionaire-Maker Stock? | The Motley Fool
11:17am, Sunday, 28'th Jun 2020
After a $1.4 billion merger, can Invitae become an industry leader in genetic testing and cancer diagnostics?
Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger between Invitae Corporation (NYSE: NVTA) and ArcherDX is fair to Invitae shareholders. On behalf of Invitae sha
Invitae's Market Opportunity Grows to $45 Billion After Latest Acquisition
08:54pm, Friday, 26'th Jun 2020
Shares of medical genomics company hit all-time high after ArcherDX deal Continue reading...
Better Buy: Invitae vs. Illumina | The Motley Fool
12:13pm, Friday, 26'th Jun 2020
Illumina is practically an institution in the biotech sector, but can it outgrow an aggressive competitor?
Is Invitae (NVTA) Stock Outpacing Its Medical Peers This Year?
03:30pm, Thursday, 25'th Jun 2020
Is (NVTA) Outperforming Other Medical Stocks This Year?
InVitae (NYSE:NVTA) Sets New 52-Week High at $29.21
07:07am, Thursday, 25'th Jun 2020
InVitae Corp (NYSE:NVTA)’s share price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $29.21 and last traded at $28.95, with a volume of 4811087 shares. The
Invitae Stock – A Pure-Play on Genetics Testing
02:04am, Thursday, 25'th Jun 2020
We research and write about tech companies and stocks religiously, but we've learned the hard way that trying to cherry-pick winning stocks is a high-risk game. No matter how promising the thesis, eve
New York, New York--(Newsfile Corp. - June 24, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To view an enhanced version of this graphic, please visit:https://orders.newsfil
6 Stocks With More Room To Run
12:00am, Wednesday, 24'th Jun 2020
Stocks Analysis by Harry Boxer covering: Ballard Power Systems Inc, First Solar Inc, Dynavax Technologies Corporation, Limelight Networks Inc. Read Harry Boxer's latest article on Investing.com
After filing for IPO, ArcherDX agrees to $1.4B buyout by Invitae
06:05pm, Tuesday, 23'rd Jun 2020
ArcherDX had filed with the SEC earlier this month for a $100 million initial public offering. The two companies said combining would enable cancer patients to access a variety of testing products and
